There will be some who think I’m biased but I thought yesterday evening’s event on Asian Traditional Medicines kindly hosted by Clyde & Co in London was great.  For those of you who couldn’t join us, you missed something special.  Not many people were interested in the views across London (including the iconic landmarks of the London Eye, the Gherkin and the Shard) their attention was very much focused on the views being expressed inside Clyde and Co’s own impressive building.  The howling

At the end of April we went to a charity event to raise money for Parkinson's UK, Huntingdonshire Branch.  It was also an opportunity to pay tribute to some wonderful friends of ours, Dill (John) and Brenda Davies.

This article demonstrates not only the traditional use of cannabis as a medicine (especially in China, India and the Middle East) but also that cannabis might finally be throwing of its image of being a 'recreational' drug which does nothing but harm.

A new Regulation on nutrition and health claims made on foods could effectively gag health-food shop owners and staff from giving nutritional or health advice based on claims for certain products such as probiotics, cranberry juice, co-enzyme Q.10 Glucosamine and perhaps even prunes.

Following on from GRS' recent Herbal Press Release, Greer Deal (Director) was interviewed by NUTRAingredients.com.  The result was this release which provides the views of three different perspectives and all three make some very valid points.

So Wednesday's UK budget has resulted in GSK committing to invest in UK manufacturing.  Do you think this will turn the tide?  Will the "great" be put back into "Great Britain"?  I suppose only time will tell.

Yes the European Medicines Agency (EMA) is calling for interested parties to express their interest in participating in the activities of the Committee for Advanced Therapies (CAT).

Firstly, there is the UK Government's Red Tape Challenge.  This includes a whole section devoted to Medicines and states that over 250 regulations are within its scope.

After a very heated debate about the NHS at the 2011 One Nucleus Bench-to-Boardroom event, on Tuesday the 6th of March this year I stood in front of my audience with some trepidation.  I had learnt from last year's experience, however, and rather than trying to embrace the reforming NHS as a whole I focused on how research is now becoming an integral part of daily activities.

The Directors of GRS attended a One Nucleus Network meeting at the Babraham Research Campus on 22 February 2012.  This event focused on the R&D incentives being offered by the Australian and UK governments so it was interesting to make a comparison.